Back to search

Tumor hypoxia and heterogeneity: Challenges and opportunities for the future

Data up to Jan 2025

Published1996
Citations103
References64

Total Citations Per Year

Abstract

References (64)

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1992 • 4,631 citations

Participation of p53 protein in the cellular response to DNA damage.

1991 • 3,818 citations

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

1992 • 3,092 citations

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1993 • 2,969 citations

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.

1992 • 2,420 citations

Purification and Characterization of Hypoxia-inducible Factor 1

1995 • 2,010 citations

Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.

1994 • 1,821 citations

Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma

1992 • 1,799 citations

Cell and Environment Interactions in Tumor Microregions: The Multicell Spheroid Model

1988 • 1,755 citations

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

1993 • 1,646 citations

Redox Regulation of Fos and Jun DNA-Binding Activity in Vitro

1990 • 1,592 citations

Carbon Monoxide: a Putative Neural Messenger

1993 • 1,519 citations

Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1

1994 • 1,460 citations

NF-κB: A lesson in family values

1995 • 1,266 citations

Barriers to Drug Delivery in Solid Tumors

1994 • 1,064 citations

Regulation of the Erythropoietin Gene: Evidence That the Oxygen Sensor Is a Heme Protein

1988 • 1,042 citations

Parallel signal processing among mammalian MAPKs

1995 • 1,015 citations

MAPKs: new JNK expands the group

1994 • 949 citations

Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia.

1993 • 857 citations

Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents.

1989 • 698 citations

Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

1994 • 620 citations

Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data

1984 • 610 citations

Overexpression of Metallothionein Confers Resistance to Anticancer Drugs

1988 • 600 citations

Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis.

1995 • 598 citations

Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer.

1994 • 517 citations

The current and potential role of hyperthermia in radiotherapy

1989 • 505 citations

Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues.

1994 • 449 citations

Does carbon monoxide have a physiological function?

1991 • 425 citations

Definitive evidence for hypoxic cells influencing cure in cancer therapy.

1978 • 422 citations

SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours

1993 • 354 citations

Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy.

1994 • 315 citations

Oxygen in Human Tumors: Correlations between Methods of Measurement and Response to Therapy: Summary of a Workshop Held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland

1993 • 298 citations

Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.

1994 • 290 citations

Thionein (apometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor Spl

1991 • 252 citations

Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia.

1994 • 241 citations

Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes

1993 • 206 citations

In situ hybridization and immunohistochemical localization of heme oxygenase-2 mRNA and protein in normal rat brain: Differential distribution of isozyme 1 and 2

1992 • 191 citations

Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice.

1994 • 189 citations

Tumor Oxygenation: A New Predictive Parameter in Locally Advanced Cancer of the Uterine Cervix

1993 • 184 citations

Activation of the heat shock transcription factor by hypoxia in mammalian cells.

1990 • 173 citations

Drug Resistance in Oncology

1994 • 173 citations

Drug Resistance in Oncology

1997 • 160 citations

Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).

1994 • 151 citations

Intracapillary oxyhemoglobin saturation of malignant tumors in humans

1981 • 131 citations

The identification of heme oxygenase as a major hypoxic stress protein in Chinese hamster ovary cells

1991 • 130 citations

Mechanisms and meaning of cellular oxygen sensing in the organism

1994 • 128 citations

Induction characteristics of oxygen regulated proteins

1986 • 121 citations

Regulation of c-jun Expression during Hypoxic and Low-Glucose Stress

1994 • 104 citations

Determination of local oxygen consumption rates in tumors.

1994 • 100 citations

Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85

1991 • 94 citations

Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism

1990 • 91 citations

Therapeutic Advantage of Hypoxic Cells in Tumors: A Theoretical Study

1991 • 91 citations

Potassium-channel activation in response to low doses of gamma-irradiation involves reactive oxygen intermediates in nonexcitatory cells.

1993 • 88 citations

Regulation of c-jun expression during hypoxic and low-glucose stress.

1994 • 79 citations

Molecular Machines that Control Genes

1995 • 68 citations

Role of Zinc-Coordination and of the Glutathione Redox Couple in the Redox Susceptibility of Human Transcription Factor Sp1

1994 • 63 citations

Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells.

1994 • 63 citations

New trends in photobiology

1991 • 40 citations

Hypoxic stress induces reversible hypophosphorylation of pRB and reduction in cyclin A abundance independent of cell cycle progression.

1993 • 38 citations

Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908)

1992 • 25 citations

Enhancement of heme oxygenase expression and activity in A431 squamous carcinoma multicellular tumor spheroids.

1993 • 24 citations

Activation of potassium channels by hypoxia and reoxygenation in the human lung adenocarcinoma cell line A549

1993 • 23 citations

Activators of protein kinase C selectively mediate cellular cytotoxicity to hypoxic cells and not aerobic cells

1994 • 13 citations

THE DANISH HEAD AND NECK CANCER STUDY GROUP (DAHANCA) RANDOMIZED TRIALS WITH HYPOXIC RADIOSENSITIZERS IN CARCINOMA OF THE LARYNX AND PHARYNX

1992 • 10 citations

Cited By (0)

Loading...
Tumor hypoxia and heterogeneity: Challenges and opportunities for the future (1996) – Seminars in Radiation Oncology | Metascience Observatory Explorer